Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction
Clinical trial NCT01176968 · COMPLETED
Trial details
- NCT number
- NCT01176968
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-10-01
- Enrollment
- 1012
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.